Robb Gary Charles bought CORT
August 22, 2025 · Form 4 insider transaction
Robb Gary Charles bought 5,000 shares of Corcept Therapeutics Incorporated at $3.88 per share, a transaction worth $19.4K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Footnotes
Includes 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 290 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025 and 997 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.